Youcare Pharmaceutical Group Co. Ltd. A
Youcare Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It offers drugs in various forms, such as injection, lyophilized powder for injection, concentrated pills, tablets, capsules, gelatins, ointments, creams, granules, etc. The company provides drugs in various categories, including antibiotics, gastrointest… Read more
Youcare Pharmaceutical Group Co. Ltd. A (688658) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.051x
Based on the latest financial reports, Youcare Pharmaceutical Group Co. Ltd. A (688658) has a cash flow conversion efficiency ratio of 0.051x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥176.05 Million) by net assets (CN¥3.43 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Youcare Pharmaceutical Group Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Youcare Pharmaceutical Group Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Youcare Pharmaceutical Group Co. Ltd. A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Youcare Pharmaceutical Group Co. Ltd. A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NB Bancorp, Inc. Common Stock
NASDAQ:NBBK
|
0.028x |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
0.041x |
|
Taiheiyo Cement Corp
PINK:THYCY
|
0.052x |
|
Toyo Ink SC Holdings Co. Ltd
F:TO5
|
0.026x |
|
Investors Real Estate Trust
F:WXC1
|
0.040x |
|
Guangzhou Wondfo Biotech Co Ltd
SHE:300482
|
0.021x |
|
DINE S.A.B. de C.V
MX:DINEB
|
-0.024x |
|
Transcat Inc
NASDAQ:TRNS
|
0.041x |
Annual Cash Flow Conversion Efficiency for Youcare Pharmaceutical Group Co. Ltd. A (2017–2024)
The table below shows the annual cash flow conversion efficiency of Youcare Pharmaceutical Group Co. Ltd. A from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.58 Billion | CN¥438.24 Million | 0.122x | -44.01% |
| 2023-12-31 | CN¥3.60 Billion | CN¥785.49 Million | 0.218x | +820.23% |
| 2022-12-31 | CN¥4.00 Billion | CN¥-121.17 Million | -0.030x | -123.11% |
| 2021-12-31 | CN¥3.93 Billion | CN¥515.24 Million | 0.131x | -32.57% |
| 2020-12-31 | CN¥3.59 Billion | CN¥697.66 Million | 0.195x | -32.65% |
| 2019-12-31 | CN¥1.12 Billion | CN¥324.94 Million | 0.289x | +26.35% |
| 2018-12-31 | CN¥842.76 Million | CN¥192.70 Million | 0.229x | -24.22% |
| 2017-12-31 | CN¥711.86 Million | CN¥214.81 Million | 0.302x | -- |